There are 116 resources available
Welcome and introduction
Presenter: Javier Sastre Varela
Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm
Resources:
Webcast
Scanning the horizon of biomarker-driven treatment for advanced G/GEJ adenocarcinoma
Presenter: Javier Sastre Varela
Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm
Resources:
Webcast
Shining a light on the potential challenges and solutions to integrating new biomarker tests
Presenter: Frederique Penault-Llorca
Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm
Resources:
Webcast
A look ahead into the practicalities of an evolving treatment paradigm
Presenter: Nicola Fazio
Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm
Resources:
Webcast
Preparing for smooth sailing: panel discussion and Q&A
Presenter: Javier Sastre Varela, Frederique Penault-Llorca, Nicola Fazio
Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm
Resources:
Webcast
Introduction
Presenter: Peter Schmid
Session: Stemline. A Menarini Group - Treatment Strategies and Sequencing After ET + CDK4/6i for Patients with ER+/HER2− Advanced Breast Cancer
Resources:
Webcast
Treatment Landscape for ER+/HER2− Advanced Breast Cancer
Presenter: Virginia Kaklamani
Session: Stemline. A Menarini Group - Treatment Strategies and Sequencing After ET + CDK4/6i for Patients with ER+/HER2− Advanced Breast Cancer
Resources:
Webcast
Emerging Biomarkers in Breast Cancer
Presenter: Frederik Marmé
Session: Stemline. A Menarini Group - Treatment Strategies and Sequencing After ET + CDK4/6i for Patients with ER+/HER2− Advanced Breast Cancer
Resources:
Webcast
Key Takeaways
Presenter: Peter Schmid
Session: Stemline. A Menarini Group - Treatment Strategies and Sequencing After ET + CDK4/6i for Patients with ER+/HER2− Advanced Breast Cancer
Resources:
Webcast
Discussion and Q&A
Presenter: Peter Schmid, Virginia Kaklamani, Frederik Marmé
Session: Stemline. A Menarini Group - Treatment Strategies and Sequencing After ET + CDK4/6i for Patients with ER+/HER2− Advanced Breast Cancer
Resources:
Webcast